This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • A comparative treatment study of VCZ and liposomal AmpB in an Aspergillus fumigatus endophthalmitis model

A comparative treatment study of VCZ and liposomal AmpB in an Aspergillus fumigatus endophthalmitis model
Reviewed by Wai Siene Ng

1 February 2016 | Wai Siene Ng | EYE - Vitreo-Retinal

This study aims to compare the effects of voriconazole (VCZ) and liposomal amphotericin B (AmpB) in an experimental model of exogenous Aspergillus fumigatus endophthalmitis in a guinea pig animal model. Endophthalmitis was induced by intravitreal injection of a strain of aspergillus isolated from a patient with fungal endophthalmitis. Thirty animals of similar weight were divided into three groups; a control group receiving balanced salt solution intravitreal injections, a VCZ group receiving 20μg/0.02mL intravitreal injections of VCZ and an AmpB group receiving 20μg/0.02mL of AmpB. These were administered 24 hours after Aspergillus inoculation and repeated every 24 hours for a total of three injections. They also calculated a minimum inhibitory concentration value for both antifungals, which were consistent with the results, reported by Clinical and Laboratory Standards Institute and doses administered intravitreally were much higher than these. Clinical inflammation using a published grading scale was used until day 28. Furthermore, smears and cultures were performed weekly, as well as serial electroretinogram recordings and histopathology of whole eye at the end of 28 days. Reassuringly both antifungal treatments demonstrated antifungal effects when compared to the control. Control eyes showed marked progressive inflammation but antifungal treatment groups showed inflammation, which gradually subsided. ERG in control groups demonstrated obvious reduction in b wave amplitude where else both antifungal groups did not. There was a significant difference in clinical inflammation and ERG recordings from day seven to 14 showing AmpB was less effective than VCZ, but this was not observed at later stage outcomes, therefore it is hard to conclude that VCZ is superior although the authors claims this. This study is enlightening as it allows for a controlled in vivo experiment for exogenous fungal endophthalmitis which would normally not be possible in patients due to variable inoculation times of infection, presentations and not to mention ethics.

A comparative treatment study of intravitreal voriconazole and liposomal amphotericin B in an Aspergillus fumigatus endophthalmitis model.
Zhao J, Cheng Y, Song X, 
INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE
2015;56:7369-76.
Share This
CONTRIBUTOR
Wai Siene Ng

University Hospital of Wales, Cardiff, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency